Artificial Metalloenzymes on the Verge of New-to-Nature Metabolism

Trends in Biotechnology

Volumn 36, Issue 1, 2018, Pages 60-72

  Jeschek, Markus ^a   Panke, Sven ^a   Ward, Thomas R ^b  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

artificial metalloenzymes; biocatalysis; directed evolution; synthetic biology; xenobiology

Indexed keywords

ASTROBIOLOGY; ENZYMES; TRANSITION METALS;

ARTIFICIAL METALLOENZYMES; BIOCATALYSIS; COMPLEX ENVIRONMENTS; DIRECTED EVOLUTION; SUSTAINABLE PRODUCTION; SYNTHETIC BIOLOGY; TRANSITION METAL CATALYSTS; WHOLE-CELL BIOTRANSFORMATIONS;

BIOLOGY;

ARTIFICIAL METALLOENZYME; ENZYME; MOLECULAR SCAFFOLD; UNCLASSIFIED DRUG; METALLOPROTEIN;

BIOCATALYST; COVALENT BOND; ENANTIOSELECTIVITY; ENZYME ENGINEERING; HYDROGENATION; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROCESS OPTIMIZATION; PROTEIN EXPRESSION; REVIEW; SCREENING TEST; STEREOSELECTIVITY; SYNTHETIC BIOLOGY; BIOCATALYSIS; BIOTECHNOLOGY; GENETICS; METABOLISM; PROCEDURES; PROTEIN ENGINEERING; TRENDS;

BIOCATALYSIS; BIOTECHNOLOGY; METALLOPROTEINS; PROTEIN ENGINEERING;

EID: 85031755986     PISSN: 01677799     EISSN: 18793096     Source Type: Journal    
DOI: 10.1016/j.tibtech.2017.10.003     Document Type: Review

References (81)

1. Bornscheuer, U.T., et al. Engineering the third wave of biocatalysis. Nature 485 (2012), 185–194.
2. Bornscheuer, U.T., Chemical biology: a radical change in enzyme catalysis. Nature 540 (2016), 345–346.
3. Hyster, T.K., Ward, T.R., Genetic optimization of metalloenzymes: enhancing enzymes for non-natural reactions. Angew. Chem. Int. Ed. Engl. 55 (2016), 7344–7357.
4. Wilson, M.E., Whitesides, G.M., Conversion of a protein to a homogeneous asymmetric hydrogenation catalyst by site-specific modification with a diphosphinerhodium(I) moiety. J. Am. Chem. Soc. 100 (1978), 306–307.
5. Lewis, J.C., Artificial metalloenzymes and metallopeptide catalysts for organic synthesis. ACS Catal. 3 (2013), 2954–2975.
6. Ilie, A., Reetz, M.T., Directed evolution of artificial metalloenzymes. Isr. J. Chem. 55 (2015), 51–60.
7. Renata, H., et al. Expanding the enzyme universe: accessing non-natural reactions by mechanism-guided directed evolution. Angew. Chem. Int. Ed. Engl. 54 (2015), 3351–3367.
8. Upp, D.M., Lewis, J.C., Selective C–H bond functionalization using repurposed or artificial metalloenzymes. Curr. Opin. Chem. Biol. 37 (2017), 48–55.
9. Hammer, S.C., et al. Design and evolution of enzymes for non-natural chemistry. Curr. Opin. Green Sustain. Chem. 7 (2017), 23–30.
10. Obexer, R., et al. Emergence of a catalytic tetrad during evolution of a highly active artificial aldolase. Nat. Chem. 9 (2017), 50–56.
11. Dydio, P., et al. Chemoselective, enzymatic C–H bond amination catalyzed by a cytochrome P450 containing an Ir(Me)–PIX cofactor. J. Am. Chem. Soc. 139 (2017), 1750–1753.
12. Kan, S.B., et al. Directed evolution of cytochrome c for carbon–silicon bond formation: bringing silicon to life. Science 354 (2016), 1048–1051.
13. Coelho, P.S., et al. Olefinic cyclopropanation via carbene transfer catalyzed by engineered cytochrome P450 enzymes. Science 339 (2013), 307–310.
14. Bajaj, P., et al. Gram-scale synthesis of chiral cyclopropane-containing drugs and drug precursors with engineered myoglobin catalysts featuring complementary stereoselectivity. Angew. Chem. Int. Ed. Engl. 55 (2016), 16110–16114.
15. Tinoco, A., et al. Highly diastereo- and enantioselective synthesis of trifluoromethyl-substituted cyclopropanes via myoglobin-catalyzed transfer of trifluoromethylcarbene. J. Am. Chem. Soc. 139 (2017), 5293–5296.
16. Coelho, P.S., et al. A serine-substituted P450 catalyzes highly efficient carbene transfer to olefins in vivo. Nat. Chem. Biol. 9 (2013), 485–487.
17. Song, W.J., Tezcan, F.A., A designed supramolecular protein assembly with in vivo enzymatic activity. Science 346 (2014), 1525–1528.
18. Jeschek, M., et al. Directed evolution of artificial metalloenzymes for in vivo metathesis. Nature 537 (2016), 661–665.
19. Kohler, V., et al. Synthetic cascades are enabled by combining biocatalysts with artificial metalloenzymes. Nat. Chem. 5 (2013), 93–99.
20. Okamoto, Y., et al. An NAD(P)H-dependent artificial transfer hydrogenase for multienzymatic cascades. J. Am. Chem. Soc. 138 (2016), 5781–5784.
21. Liu, Z., et al. Upregulation of an artificial zymogen by proteolysis. Angew. Chem. Int. Ed. Engl. 55 (2016), 11587–11590.
22. Bersellini, M., Roelfes, G., A metal ion regulated artificial metalloenzyme. Dalton Trans. 46 (2017), 4325–4330.
23. Okamoto, Y., Ward, T.R., Cross-regulation of an artificial metalloenzyme. Angew. Chem. Int. Ed. Engl. 56 (2017), 1–6.
24. Sasmal, P.K., et al. Metal complex catalysis in living biological systems. Chem. Commun. 49 (2013), 1581–1587.
25. Volker, T., et al. Progress towards bioorthogonal catalysis with organometallic compounds. Angew. Chem. Int. Ed. Engl. 53 (2014), 10536–10540.
26. Bordeaux, M., et al. Highly diastereoselective and enantioselective olefin cyclopropanation using engineered myoglobin-based catalysts. Angew. Chem. Int. Ed. Engl. 54 (2015), 1744–1748.
27. Farwell, C.C., et al. Enantioselective enzyme-catalyzed aziridination enabled by active-site evolution of a cytochrome P450. ACS Cent. Sci. 1 (2015), 89–93.
28. McIntosh, J.A., et al. Enantioselective intramolecular C–H amination catalyzed by engineered cytochrome P450 enzymes in vitro and in vivo. Angew. Chem. Int. Ed. Engl. 52 (2013), 9309–9312.
29. 3)–H amination of arylsulfonyl azides with engineered and artificial myoglobin-based catalysts. Bioorgan. Med. Chem. 22 (2014), 5697–5704.
30. Hyster, T.K., et al. Enzyme-controlled nitrogen-atom transfer enables regiodivergent C–H amination. J. Am. Chem. Soc. 136 (2014), 15505–15508.
31. Prier, C.K., et al. Enantioselective, intermolecular benzylic C–H amination catalysed by an engineered iron–haem enzyme. Nat. Chem. 9 (2017), 629–634.
32. Farwell, C.C., et al. Enantioselective imidation of sulfides via enzyme-catalyzed intermolecular nitrogen-atom transfer. J. Am. Chem. Soc. 136 (2014), 8766–8771.
33. Prier, C.K., et al. Asymmetric enzymatic synthesis of allylic amines: a sigmatropic rearrangement strategy. Angew. Chem. Int. Ed. Engl. 55 (2016), 4711–4715.
34. Wang, Z.J., et al. Cytochrome P450-catalyzed insertion of carbenoids into N–H bonds. Chem. Sci. 5 (2014), 598–601.
35. Sreenilayam, G., Fasan, R., Myoglobin-catalyzed intermolecular carbene N–H insertion with arylamine substrates. Chem. Commun., 51, 2015, 1744.
36. Tyagi, V., et al. Intermolecular carbene S–H insertion catalysed by engineered myoglobin-based catalysts. Chem. Sci. 6 (2015), 2488–2494.
37. Matthews, M.L., et al. Direct nitration and azidation of aliphatic carbons by an iron-dependent halogenase. Nat. Chem. Biol. 10 (2014), 209–215.
38. Zastrow, M.L., et al. Hydrolytic catalysis and structural stabilization in a designed metalloprotein. Nat. Chem. 4 (2012), 118–123.
39. Dieckmann, G.R., et al. De novo design of mercury-binding two- and three-helical bundles. J. Am. Chem. Soc. 119 (1997), 6195–6196.
40. 2. Angew. Chem. Int. Ed. Engl. 53 (2014), 7900–7903.
41. Khare, S.D., et al. Computational redesign of a mononuclear zinc metalloenzyme for organophosphate hydrolysis. Nat. Chem. Biol. 8 (2012), 294–300.
42. 3)–H bond hydroxylation catalyzed by myoglobin reconstituted with manganese porphycene. J. Am. Chem. Soc. 135 (2013), 17282–17285.
43. Key, H.M., et al. Abiological catalysis by artificial haem proteins containing noble metals in place of iron. Nature 534 (2016), 534–537.
44. Dydio, P., et al. An artificial metalloenzyme with the kinetics of native enzymes. Science 354 (2016), 102–106.
45. Reynolds, E.W., et al. An evolved orthogonal enzyme/cofactor pair. J. Am. Chem. Soc. 138 (2016), 12451–12458.
46. Yang, H., et al. A general method for artificial metalloenzyme formation through strain-promoted azide–alkyne cycloaddition. Chembiochem 15 (2014), 223–227.
47. Srivastava, P., et al. Engineering a dirhodium artificial metalloenzyme for selective olefin cyclopropanation. Nat. Commun., 6, 2015, 7789.
48. Hyster, T.K., et al. Biotinylated Rh(III) complexes in engineered streptavidin for accelerated asymmetric C–H activation. Science 338 (2012), 500–503.
49. Yu, F.T., et al. Protein design: toward functional metalloenzymes. Chem. Rev. 114 (2014), 3495–3578.
50. Besenmatter, W., et al. Relative tolerance of mesostable and thermostable protein homologs to extensive mutation. Proteins Struct. Funct. Bioinf. 66 (2007), 500–506.
51. Tokuriki, N., Tawfik, D.S., Stability effects of mutations and protein evolvability. Curr. Opin. Struct. Biol. 19 (2009), 596–604.
52. Reetz, M.T., et al. A robust protein host for anchoring chelating ligands and organocatalysts. Chembiochem 9 (2008), 552–564.
53. Fujieda, N., et al. A well-defined osmium–cupin complex: hyperstable artificial osmium peroxygenase. J. Am. Chem. Soc. 139 (2017), 5149–5155.
54. Cereghino, J.L., Cregg, J.M., Heterologous protein expression in the methylotrophic yeast Pichia pastoris. FEMS Microbiol. Rev. 24 (2000), 45–66.
55. Nogueira, E.S., et al. High-level secretion of recombinant full-length streptavidin in Pichia pastoris and its application to enantioselective catalysis. Protein Expr. Purif. 93 (2014), 54–62.
56. Delcour, A.H., Outer membrane permeability and antibiotic resistance. Biochim. Biophys. Acta Proteins Proteomics 1794 (2009), 808–816.
57. Tong, Y., Guo, M., Bacterial heme-transport proteins and their heme-coordination modes. Arch. Biochem. Biophys. 481 (2009), 1–15.
58. Richter, M.F., et al. Predictive compound accumulation rules yield a broad-spectrum antibiotic. Nature 545 (2017), 299–304.
59. Jeschek, M., et al. Periplasmic screening for artificial metalloenzymes. Methods Enzymol. 580 (2016), 539–556.
60. Lelyveld, V.S., et al. Metal-substituted protein MRI contrast agents engineered for enhanced relaxivity and ligand sensitivity. J. Am. Chem. Soc. 133 (2011), 649–651.
61. Krewinkel, M., et al. Engineering of an E. coli outer membrane protein FhuA with increased channel diameter. J. Nanobiotechnol., 9, 2011, 33.
62. Chen, G., et al. Isolation of high-affinity ligand-binding proteins by periplasmic expression with cytometric screening (PECS). Nat. Biotechnol. 19 (2001), 537–542.
63. Wallace, S., Balskus, E.P., Designer micelles accelerate flux through engineered metabolism in E. coli and support biocompatible chemistry. Angew. Chem. Int. Ed. Engl. 55 (2016), 6023–6027.
64. Wang, L., et al. Expanding the genetic code of Escherichia coli. Science 292 (2001), 498–500.
65. Reiner, T., et al. Metal-conjugated affinity labels: a new concept to create enantioselective artificial metalloenzymes. ChemistryOpen 2 (2013), 50–54.
66. Podtetenieff, J., et al. An artificial metalloenzyme: creation of a designed copper binding site in a thermostable protein. Angew. Chem. Int. Ed. Engl. 49 (2010), 5151–5155.
67. Lee, H.S., Schultz, P.G., Biosynthesis of a site-specific DNA cleaving protein. J. Am. Chem. Soc. 130 (2008), 13194–13195.
68. Drienovska, I., et al. Novel artificial metalloenzymes by in vivo incorporation of metal-binding unnatural amino acids. Chem. Sci. 6 (2015), 770–776.
69. Jeschek, M., et al. Biotin-independent strains of Escherichia coli for enhanced streptavidin production. Metab. Eng. 40 (2017), 33–40.
70. Monnard, F.W., et al. Human carbonic anhydrase II as a host for piano-stool complexes bearing a sulfonamide anchor. Chem. Commun. 47 (2011), 8238–8240.
71. Zhao, J.M., et al. Carbonic anhydrase II as host protein for the creation of a biocompatible artificial metathesase. Org. Biomol. Chem. 13 (2015), 5652–5655.
72. Ricoux, R., et al. Hemozymes peroxidase activity of artificial hemoproteins constructed from the Streptomyces lividans xylanase A and iron(III)-carboxy-substituted porphyrins. Bioconjug. Chem. 19 (2008), 899–910.
73. Allard, M., et al. Incorporation of manganese complexes into xylanase: new artificial metalloenzymes for enantioselective epoxidation. Chembiochem 13 (2012), 240–251.
74. Chevalley, A., et al. Artificial metalloenzymes derived from bovine beta-lactoglobulin for the asymmetric transfer hydrogenation of an aryl ketone – synthesis, characterization and catalytic activity. Dalton Trans. 43 (2014), 5482–5489.
75. Wilson, Y.M., et al. Neutralizing the detrimental effect of glutathione on precious metal catalysts. J. Am. Chem. Soc. 136 (2014), 8928–8932.
76. Wallace, S., Balskus, E.P., Interfacing microbial styrene production with a biocompatible cyclopropanation reaction. Angew. Chem. Int. Ed. Engl. 54 (2015), 7106–7109.
77. Otte, K.B., Hauer, B., Enzyme engineering in the context of novel pathways and products. Curr. Opin. Biotechnol. 35 (2015), 16–22.
78. Erb, T.J., et al. Synthetic metabolism: metabolic engineering meets enzyme design. Curr. Opin. Chem. Biol. 37 (2017), 56–62.
79. Hepworth, L.J., et al. Enzyme cascades in whole cells for the synthesis of chiral cyclic amines. ACS Catal. 7 (2017), 2920–2925.
80. Tsubokura, K., et al. In vivo gold complex catalysis within live mice. Angew. Chem. Int. Ed. Engl. 56 (2017), 3579–3584.
81. Ball, Z.T., Designing enzyme-like catalysts: a rhodium(II) metallopeptide case study. Acc. Chem. Res. 46 (2013), 560–570.